Suppr超能文献

银屑病的遗传易感性及相关基因与治疗选择的关系。

The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options.

机构信息

Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC 27104, USA.

The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Int J Mol Sci. 2023 Aug 1;24(15):12310. doi: 10.3390/ijms241512310.

Abstract

Understanding the factors creating genetic susceptibility in psoriasis may provide a basis for improving targeted treatment strategies. In this review, we discuss the genes linked to the pathogenesis of psoriasis and their relationship to the available treatment options. To identify the relevant genetic markers and treatments, we searched PubMed, Google Scholar, MEDLINE, and Web of Science with keywords, including , , , and . The articles in English from database inception to 1/1/23 were included. Case reports and series were excluded. Gene variant forms commonly implicated in the pathogenesis of psoriasis include those encoding for interleukins, interferons, and other mediators involved in inflammatory pathways, such as JAK/STAT, and NF-κB. Several of the treatments for psoriasis (for example IL23 and TYK2 inhibitors) target the products of genes linked to psoriasis. Multiple genes are linked to the pathogenesis of psoriasis. This understanding may provide an avenue for the development of new psoriasis treatment strategies and for more effective, safer treatment outcomes.

摘要

了解导致银屑病遗传易感性的因素可能为改善靶向治疗策略提供基础。在这篇综述中,我们讨论了与银屑病发病机制相关的基因及其与现有治疗选择的关系。为了确定相关的遗传标志物和治疗方法,我们使用关键词在 PubMed、Google Scholar、MEDLINE 和 Web of Science 上进行了搜索,包括 、 、 、 。纳入了从数据库建立到 2023 年 1 月 1 日的英文文章。排除了病例报告和系列。在银屑病发病机制中常见的基因变异形式包括编码白细胞介素、干扰素和其他参与炎症途径的介质的基因,如 JAK/STAT 和 NF-κB。几种银屑病治疗方法(例如 IL23 和 TYK2 抑制剂)针对与银屑病相关的基因产物。多个基因与银屑病的发病机制有关。这种认识可能为开发新的银屑病治疗策略以及更有效、更安全的治疗结果提供途径。

相似文献

4
From Empirical to Pathogenesis-Based Treatments for Psoriasis.从经验性治疗到基于发病机制的银屑病治疗。
J Invest Dermatol. 2022 Jul;142(7):1778-1785. doi: 10.1016/j.jid.2022.01.014. Epub 2022 Mar 3.
5
Advances in psoriasis research: From pathogenesis to therapeutics.银屑病研究进展:从发病机制到治疗学。
Life Sci. 2024 Oct 15;355:122991. doi: 10.1016/j.lfs.2024.122991. Epub 2024 Aug 15.
7
TYK2 as a novel therapeutic target in psoriasis.TYK2 作为银屑病的一个新的治疗靶点。
Expert Rev Clin Pharmacol. 2023 Jan-Jun;16(6):549-558. doi: 10.1080/17512433.2023.2219054. Epub 2023 Jun 7.
10
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.泛发性脓疱型银屑病患者的治疗选择和目标。
Am J Clin Dermatol. 2022 Jan;23(Suppl 1):51-64. doi: 10.1007/s40257-021-00658-9. Epub 2022 Jan 21.

本文引用的文献

1
Spesolimab: First Approval.斯帕斯单抗:首次批准。
Drugs. 2022 Nov;82(17):1681-1686. doi: 10.1007/s40265-022-01801-4.
2
Deucravacitinib: First Approval.地达西布替尼:首次获批
Drugs. 2022 Nov;82(17):1671-1679. doi: 10.1007/s40265-022-01796-y.
3
Genetics of psoriasis: a basis for precision medicine.银屑病的遗传学:精准医学的基础
Precis Clin Med. 2019 Jun 24;2(2):120-130. doi: 10.1093/pcmedi/pbz011. eCollection 2019 Jun.
4
Pustular Psoriasis: From Pathophysiology to Treatment.脓疱型银屑病:从病理生理学到治疗
Biomedicines. 2021 Nov 23;9(12):1746. doi: 10.3390/biomedicines9121746.
7
Psoriasis.银屑病。
Lancet. 2021 Apr 3;397(10281):1301-1315. doi: 10.1016/S0140-6736(20)32549-6.
10
Current Developments in the Immunology of Psoriasis.银屑病免疫学的最新进展。
Yale J Biol Med. 2020 Mar 27;93(1):97-110. eCollection 2020 Mar.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验